BioSpace News Archive

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announces that the complete line of PrTeva-Aripiprazole

“When I was a kid, I broke both of my wrists and therefore had very weak wrists, which led to trouble with lifting weights,” said an inventor from San Juan, Texas. “Since push-ups are my best exercise, I came up with the idea of combining them with a grip-strengthening exercise so that they also targeted the muscles in the fingers, hands, wrists and forearms.”

MILabs announces that is has successfully completed the installation of its next-generation Adaptive U-CTXUHR at Sydney Imaging, a Core Research Facility of the University of Sydney.

bioLIVE – the new bioprocessing and manufacturing event running alongside this year’s CPhI Worldwide – today announces the initial findings of the world’s first ever biopharma league table, which evaluates the reputations of major bio manufacturing countries across a number of characteristics (scored 1-10). This follows the launch of the small molecule pharma league table introduced last year.

In recognition of National Suicide Prevention Month, the National Shooting Sports Foundation (NSSF), the trade association for the firearms industry, and Project ChildSafe, NSSF’s national firearms safety education program, are reminding gun owners that securely storing their firearms could help save the life of someone going through a difficult time.

Baylis Medical Company announced the official commercial launch of its SureFlex® Steerable Guiding Sheath.

Technavio has announced their latest pipeline analysis report on the drug pipeline for laryngeal cancer. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat laryngeal cancer.

Florida Hospice & Palliative Care Association presented Rep. Travis Cummings (R), Orange Park the “2018 Hospice Champion Award” on August 23rd.

The IXORA-R study will be the first H2H trial between an IL-17 and IL-23 using the Psoriasis Area Severity Index (PASI) 100 score as the primary endpoint.

Dr. Bertalan Mesko, “The Medical Futurist,” and Dave deBronkart, “e-Patient Dave” as the opening and closing keynote speakers for FutureLink, taking place November 5 - 7 in Chicago.